2017-2018 Executive Committee
Staff Liaison: Anne Kreiss (akreiss@myAST.org)
Chair: Alejandro Soto-Gutierrez (2019)
Co-Chair: Giuseppe Orlando (2019)
Past Chair: Jason Wertheim (2019)
Board Liaison: Dianne McKay (2018)
Kenneth Brayman (2018)
Amir Dorafshar (2018)
Harald Ott (2018)
Kim Solez (2019)
Trainee: Astgik Petrosyan (2018)
- Engage the TRM COP in educational activities with other societies focused on transplantation, bioengineering, and cell biology. Ongoing planning and conversations center on the organization of sessions that incorporate topics in Regenerative Medicine and Transplantation with the new Cell Transplant and Regenerative Medicine Society (CTRMS), Tissue Engineering International & Regenerative Medicine Society (TERMIS), and other Transplant societies (Canadian Society of Transplantation, Latino-American, and Caribbean Transplant Society). This, we hope; will increase collaboration, communication, and visualization of the TRM COP and help AST branch out into more communities throughout the year.
- Propose educational/scientific program for ATC 2018.
- Await word from TERMIS on proposed sessions for December 2017 meeting (application submitted in early 2017).
- Reach out to scientific communities dedicated to new emerging technologies that are merging with transplant science. These scientific communities include specialist in blastocyst complementation for personalized organ generation and gene editing (CRISPR) for genetic reprogramming of disease. We will encourage participation and incorporation as new members of AST to increase our own community and bridge the basic science with the transplant community throughout the year.
- Develop a white paper in tissue engineering and transplantation.
- Our Mission statement is completed. We will undertake an annual review.
- Develop the TRM COP’s strategic plan within 9 to 12 months.
- In the area of education, we plan to provide TRM COP members with a list (updated bi-weekly) of relevant, new published manuscripts related to the mission of TRM COP. This will increase the knowledge of our community in topics of regenerative medicine that can be integrated in transplantation and will keep them updated.
- Nominate members to AST Board or leadership positions.
- We will reach out to the newly established Tissue Biofabrication Manufacturing Consortium funded in part by the Department of Defense. The AST TRM COP submitted a response in 2016 to the AST Board of Directors for RFI-AFRL-RQKM-2016-0009 that provided information to the DoD in support of tissue biofabrication. We will offer our TRM COP as a forum for academic education and collaboration of our members on their initiatives and efforts to manufacture human tissue for transplantation (within 3 to 12 months).
- Continue to engage new Organ and Tissue Preservation (OTP) Community of Practice on new joint activities.
- Encourage members to share ideas and suggest initiatives via AST Hub.
- Sustain COP-to-AST membership conversion.
- Provide regular updates to COP members and AST Board.